SHILPAMED.NSSHILPAMED.NSNSE
Loading
EV to Sales HistoryFair Value
Percentile Rank86
3Y CAGR+15.8%
5Y CAGR+15.7%
Studio
Year-over-Year Change

Enterprise value to sales ratio

3Y CAGR
+15.8%/yr
vs -9.3%/yr prior
5Y CAGR
+15.7%/yr
Consistent
Acceleration
+25.1pp
Accelerating
Percentile
P86
Within normal range
vs 5Y Ago
2.1x
Strong expansion
Streak
2 yr
Consecutive growthFair Value
PeriodValueYoY Change
20255.41+19.9%
20244.51+70.5%
20232.65-24.1%
20223.49-8.8%
20213.83+46.8%
20202.61-37.0%
20194.14-19.8%
20185.16-26.3%
20177.00+31.9%
20165.30-